Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Maria Gastanaga"'
Autor:
David M. Roth, Deborah M. Levy, Michael Henrickson, Inmaculada Calvo Penades, Carlos Abud-Mendoza, Michael Shishov, Vyacheslav Chasnyk, Julia E Calderon, Antonio Nino, Diego O Viola, Alina Boteanu, Manuel A. Ferrandiz, Maria Gastanaga, Herbert Struemper, Mei-Lun Wang, Anne E. Hammer, Kenneth L. Clark, Hermine I. Brunner, Beulah Ji, Vladimir Keltsev, Nicolino Ruperto, Daniel J. Lovell, Jordi Anton, Damon Bass, Alberto Martini
Publikováno v:
Annals of the Rheumatic Diseases
ObjectivesThis ongoing Phase-2, randomised, placebo-controlled, double-blind study evaluated the efficacy, safety and pharmacokinetics of intravenous belimumab in childhood-onset systemic lupus erythematosus (cSLE).MethodsPatients (5 to 17 years) wer
Autor:
Hermine I. Brunner, D. Kingsbury, A Martini, Inmaculada Calvo, Johannes Breedt, R. Wong, Daniel J. Lovell, N Ruperto, Maria Gastanaga, J. Zhuo, M. Askelson, G. Horneff, C. Wouters, Ingrid Louw, Nikolay Tzaribachev, Ivan Foeldvari, F. Zapata, Marleen Nys
Publikováno v:
Annals of the Rheumatic Diseases. 79:485-486
Background:Maintenance of clinical response over time has been shown in individual patients (pts) with polyarticular-course juvenile idiopathic arthritis (pJIA) treated with SC abatacept (ABA).1It is unknown whether each individual pt with sustained
Autor:
Gerd Horneff, Daniel J. Lovell, Johannes Breedt, Thomas Lutz, Nadina Rubio, Nicolino Ruperto, Hermine I. Brunner, Daniel J. Kingsbury, Marleen Nys, Inmaculada Calvo, R. Wong, Nikolay Tzaribachev, Ingrid Louw, Y. Elbez, Alberto Martini, Ivan Foeldvari, Tatiana Miraval, Carine Wouters, Maria Gastanaga, Rik Joos, Francisco Zapata
Publikováno v:
Oral Presentations.
Background The efficacy of SC abatacept (ABA) in patients (pts) with polyarticular-course juvenile idiopathic arthritis (pJIA) was shown in a 2-year (yr), Phase III, open-label international study (NCT01844518).1 However, it is unknown whether each i
Autor:
Damon Bass, Hermine I. Brunner, Herbert Struemper, Daniel J. Lovell, Anne E. Hammer, Antonio Nino, Michael Shishov, Mei-Lun Wang, Beulah Ji, Kenneth L. Clark, Vladimir Keltsev, Julia Calderon Gallegos, Alberto Martini, Vyacheslav Chasnyk, Jordi Anton, David M. Roth, Manuel A. Ferrandiz, Alina Boteanu, Carlos Abud-Mendoza, Inmaculada Calvo, Maria Gastanaga, Deborah M. Levy, Nicolino Ruperto, Diego O Viola, Michael Henrickson
Publikováno v:
Poster Presentations.
Background: Belimumab (BEL), a monoclonal antibody targeting the B-lymphocyte stimulator, is approved in adults with active systemic lupus erythematosus (SLE). This is the first clinical trial of belimumab in pediatric patients with childhood-onset S